|

Testing a Mammography Decision Intervention in a Rural Setting

RECRUITINGN/ASponsored by Dartmouth-Hitchcock Medical Center
Actively Recruiting
PhaseN/A
SponsorDartmouth-Hitchcock Medical Center
Started2025-09-01
Est. completion2026-05-01
Eligibility
Age39 Years – 49 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

The overall objective of this COBRE pilot project is to enhance the design of a 3-arm cluster randomized trial that will test the efficacy and mechanism of effect of the MyMammogram DA with or without a provider communication intervention. This will be accomplished through two aims: (1) Refine, with community partner input, a clinical trial protocol to optimize engagement among patients and primary care providers (PCPs) practicing in rural settings. In consultation with patients, PCPs, and informatics experts, the study team will refine site selection, randomization, patient and PCP recruitment, and data collection protocols to meet the needs of the rural health care delivery system and participants. The result of this aim will be a modified protocol and intervention strategy that is acceptable to partners. (2) Adapt and test trial and intervention implementation features to achieve protocol acceptance and adherence. The investigators will pilot the adapted three-arm randomized trial protocol in rural primary care settings that compares the MyMammogram DA with or without a risk summary provided to the PCP pre-visit, relative to usual care. Implementing the trial in two phases (n=15 each) will systematically identify barriers and facilitators to trial participation to refine protocols. Participants will receive acceptability surveys and investigators will conduct qualitative interviews with patients and PCPs to understand experiences with trial implementation from multiple perspectives.

Eligibility

Age: 39 Years – 49 YearsSex: FEMALEHealthy volunteers accepted
Patient Inclusion Criteria:

* Females
* Aged 39-49
* Upcoming appointment with a participating primary care provider (within 4 weeks)
* English or Spanish-speaking

Patient Exclusion Criteria:

* Personal history of breast cancer (including lobular carcinoma in situ and ductal carcinoma in situ or atypical hyperplasia)
* Mammogram in the prior 12 months

Clinician inclusion: Any practicing primary care provider at a participating site.

Conditions2

Breast CancerCancer

Locations1 site

Cheshire Medical Center
Keene, New Hampshire, 03431
Christine Gunn, PhD603-646-5430Christine.M.Gunn@dartmouth.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.